MAM
Ashish Medhekar joins Triton Mumbai as executive director
MUMBAI: Triton Communications has appointed Ashish Medhekar as executive director. In his new assignment, Medhekar will be a part of the core management team with the mandate to drive growth.
He moves in from JWT, where he was vice president and executive business director.
Medhekar said, “We are in exciting times and I am looking forward to the opportunity of taking the Triton story forward. Triton has a history of building solid brands and has long and deep rooted relationships with its clients and I look forward to partnering them and taking the relationships to the next level. The task is growth through great brand ideas and integrated solutions.”
Triton director Ali Merchant added, “Bringing with him a wealth of integrated experiences in communication, we are confident and looking forward to Ashish’s leadership role in Triton. Particularly in the areas of helping dynamic growth for our clients, converting new business opportunities into the Triton fold and building a team of professionals in each area of client need. We wish him the very best in this leadership role.”
In a career spanning over 20 years, he started his career with Contract Advertising and has worked with Agencies like Rediffusion Y&R as head of the Chennai office, Wunderman and Everest Brand Solutions where he headed the Mumbai office. He has also worked with Dentsu, and Enterprise Nexus.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
